ESC Professional Premium Access

Short and long-term antiplatelet therapy in clinical practice

Event: ESC Congress 2022
Topic: Antiplatelet Drugs
Session type: Moderated ePosters
Date: 27 August 2022
Time: 17:15 - 18:00

Congress Session

8 presentations in this session

Short dual antiplatelet therapy duration in high bleeding risk patients undergoing PCI for non-ST-elevation acute coronary syndrome

Speaker: Doctor D. Cao (Bergamo, IT)
Thumbnail

CYP2C19 loss-of-function alleles and the use of omeprazole or esomeprazole increase the risk of cardiovascular outcomes in patients using clopidogrel - a real-world study

Speaker: Mr M. Ritvos (Helsinki, FI)
Thumbnail

Bentracimab demonstrates reversal of antiplatelet effects of ticagrelor: impact of hematocrit and generic versions of ticagrelor in vitro

Speaker: Professor B. Curry (Memphis, US)
Thumbnail

Intravenous antiplatelet therapy with cangrelor vs. tirofiban in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention

Speaker: Doctor M. Centore (Salerno, IT)
Thumbnail

Comparing dual antiplatelet therapy strategies post-acute coronary syndrome: network meta-analysis

Speaker: Doctor R. Turgeon (Vancouver, CA)
Thumbnail

Thirty-days versus standard duration of dual antiplatelet treatment after percutaneous coronary interventions: a systematic review and meta-analysis

Speaker: Doctor A. Apostolos (Athens, GR)
Thumbnail

Dual antiplatelet therapy for 1 versus 3 months in high bleeding risk patients with or without oral anticoagulant therapy after coronary stenting

Speaker: Doctor D. Cao (Bergamo, IT)
Thumbnail

Real-world assessment of anti-platelet therapies for recurrent stroke prevention in non-atrial fibrillation Japanese patients after recent ischemic stroke or transient ischemic attack

Speaker: Mrs A. Kang (Lawrenceville, US)
Thumbnail

8 speakers from this session

Doctor Davide Cao

Clinical Institute Humanitas Gavazzeni, Bergamo (Italy)
1 presentation
0 follower

Mr Markus Samuel Ritvos

Helsinki University Hospital, Helsinki (Finland)
0 follower

Professor Ben Curry

MLM Medical Labs, Memphis (United States of America)
0 follower

Doctor Mario Centore

University Hospital San Giovanni di Dio e Ruggi dAragona, Salerno (Italy)
0 follower

Doctor Ricky Turgeon

University of British Columbia, Vancouver (Canada)
0 follower

Doctor Anastasios Apostolos

Hippokration General Hospital, Athens (Greece)
0 follower

Doctor Davide Cao

Clinical Institute Humanitas Gavazzeni, Bergamo (Italy)
1 presentation
0 follower

Mrs Amiee Kang

Bristol Myers Squibb, Lawrenceville (United States of America)
0 follower

This platform is supported by

logo Novo Nordisk